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Abstract
Background: Recent studies have demonstrated that activation of autophagy increases the lifespan of organisms from yeast
to flies. In contrast to the lifespan extension effect in lower organisms, it has been reported that overexpression of unc-51-
like kinase 3 (ULK3), the mammalian homolog of autophagy-specific gene 1 (ATG1), induces premature senescence in
human fibroblasts. Therefore, we assessed whether the activation of autophagy would genuinely induce premature
senescence in human cells.
Methodology/Principal Findings: Depletion of ATG7, ATG12, or lysosomal-associated membrane protein 2 (Lamp2) by
transfecting siRNA or infecting cells with a virus containing gene-specific shRNA resulted in a senescence-like state in two
strains of primary human fibroblasts. Prematurely senescent cells induced by autophagy impairment exhibited the
senescent phenotypes, similar to the replicatively senescent cells, such as increased senescence associated b-galactosidase
(SA-b-gal) activity, reactive oxygen species (ROS) generation, and accumulation of lipofuscin. In addition, expression levels
of ribosomal protein S6 kinase1 (S6K1), p-S6K1, p-S6, and eukaryotic translation initiation factor 4E (eIF4E) binding protein 1
(4E-BP1) in the mammalian target of rapamycin (mTOR) pathway and beclin-1, ATG7, ATG12-ATG5 conjugate, and the
sequestosome 1 (SQSTM1/p62) monomer in the autophagy pathway were decreased in both the replicatively and the
autophagy impairment-induced prematurely senescent cells. Furthermore, it was found that ROS scavenging by N-
acetylcysteine (NAC) and inhibition of p53 activation by pifithrin-a or knockdown of p53 using siRNA, respectively, delayed
autophagy impairment-induced premature senescence and restored the expression levels of components in the mTOR and
autophagy pathways.
Conclusion: Taken together, we concluded that autophagy impairment induces premature senescence through a ROS- and
p53-dependent manner in primary human fibroblasts.
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Introduction
Autophagy is an evolutionarily conserved catabolic process, by
which cytoplasmic proteins and organelles are engulfed in
autophagosomes and degraded after fusion with lysosomes.
Biological roles of autophagy can be illustrated in a variety of
physiological and pathophysiological conditions, such as starvation
adaptation, clearance of damaged proteins and organelles,
development, elimination of pathogens, cell survival and death,
tumor suppression, and antigen presentation [1]. In addition, it
has been suggested that autophagy can have a pro-longevity effect
in organisms from yeast to flies [2–6], although this hypothesis
remains controversial [7–8]. Furthermore, several lifespan exten-
sion interventions, including calorie restriction as well as treatment
with resveratrol, rapamycin, or spermidine, have exploited their
effects through activation of autophagy [5,9–11]. Although the
roles of autophagy in age-related diseases involving neurodegen-
erative dysfunction, such as Alzheimer’s disease, Parkinson’s
disease, Huntington’s disease [12–14], macular degeneration
[15–16], hypercholesterolemia [17], and cardiomyopathy [18],
have been implicated, the effect of autophagy on the lifespan of
mammals is still ambiguous. Mice with autophagy impairment by
the homozygous knockout of ATG5, ATG7, Beclin-1, or Ambra1
genes revealed embryonic lethality or postnatal death [19]. Mice
with a heterozygous deletion of beclin-1 showed increased signs of
morbidity, including a high incidence of spontaneous tumors [20–
21]. Moreover, deletion of the huntingtin polyglutamine tract in a
huntington’s disease mouse model with mutant huntingtin showed
enhanced longevity that was most likely related to the activation of
autophagy [22]. In contrast, overexpression of ULK3, which is an
isoform of ULK1, the mammalian homolog of ATG1, enhances
autophagy but results in premature senescence in human
fibroblasts [23]. This equivocal result brought confusion to the
precise role of autophagy in senescence. Therefore, we examined
the effect of autophagy impairment on replicative lifespan using
RNAi-mediated knockdown of 3 genes involved in autophagy
(ATG7, ATG12, and Lamp2) in two primary human fibroblasts in
order to clarify the role of autophagy during cellular senescence. In
PLoS ONE | www.plosone.org 1 August 2011 | Volume 6 | Issue 8 | e23367this study, we found that inhibition of autophagy can induce
premature senescence in primary human diploid fibroblasts in a
reactive oxygen species (ROS)- and p53-dependent manner.
Results
Autophagy impairment induces premature senescence
During autophagosome formation, ATG7 is essential for
conjugation between ATG5 and ATG12 as well as the lipidation
of LC3. The ATG12-ATG5-ATG16 complex and lipidated LC3
contribute to elongation and expansion of autophagosomal
membranes. After completion of autophagosome formation, a
fusion between the autophagosome and lysosome is required for
degradation of engulfed materials. At this fusion step, Lamp2,
which is localized at the lysosomal membrane, is critical [24]. To
assess the effect of autophagy impairment on senescence, we
transfected two primary human fibroblasts (M6 and M11)
obtained from two different healthy, young donors with siRNA
against ATG7 or Lamp2, which led to growth arrest after 4–6
population doublings (Fig. 1A). These growth-arrested cells
showed a senescent phenotype of high SA-b-gal positivity. In
addition, autofluorescence, which primarily originates from
accumulated lipofuscin [25], and enlarged morphology were
observed, which were similar to those seen in replicatively
senescent cells (data not shown). We next established human
fibroblast cell lines that were stably expressing shRNA against
ATG7, ATG12, or Lamp2. Using stable cell lines with reduced
expression of the respective genes, we confirmed the senescence-
inducing effect of autophagy impairment on replicative lifespan.
Cells stably expressing shRNA against ATG7, ATG12, or Lamp2
entered a senescence-like growth-arrested state after 5–7 passages
(5–11 population doublings), while cells expressing control shRNA
entered senescence after 15 passages (26 population doublings)
(Fig. 1A). The stable cell lines that expressed shRNA against
ATG7, ATG12, or Lamp2 showed high SA-b-gal positivity
(Fig. 1C, D), autofluorescence, and enlarged morphology (Fig. 1C).
These results were similar to replicatively senescent cells.
Furthermore, transmission electron microscopy showed that
autophagy-impaired cell lines at lower passage number exhibited
a similar increase of autophagic vacuoles as the replicatively
senescent control cell line (Fig. 2E vs. 2F–H), while these cells at
very early passage number showed a small number of autophagic
vacuoles as young control cell line (Fig.2A vs. 2B–D). In the
senescent control cell line, a majority of degenerative autophagic
vacuoles (AVd) contained remnants of partially degraded materials,
while a minority of AVd showed multi-vesicular or lamellated
structures (Fig. 2E). However, in prematurely senescent autophagy-
impaired cell lines, the majority of AVd showed multi-vesicular or
Figure 1. Autophagy impairment induces premature senescence of human fibroblasts. (A) Two strains of primary human fibroblasts were
transfected with siRNA to ATG7 or Lamp2 and counted every 3 d for 21 d. Upon confluency, the cells were passaged. Cells transfected with ATG7 and
Lamp2 siRNA show reduced proliferation. (B) Stable cell lines expressing shRNA against ATG7, ATG12, and Lamp2 show reduced replicative lifespan.
(C) Upper panel: representative micrograph of SA-b-gal staining of stable cell lines at passage 8; Lower panel: representative fluorescence micrograph
of autofluorescence of stable cell lines at passage 8. (D) Bars represent the percentage of SA-b-gal positive cells.
doi:10.1371/journal.pone.0023367.g001
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of partially degraded materials (Fig. 2F–H). Accordingly, these data
implicate that autophagy impairment can induce premature
senescence in primary human fibroblasts.
Phenotypic characteristics of autophagy impairment-
induced prematurely senescent cells
To compare the senescent features of autophagy impairment-
induced prematurely senescent cells (hereafter referred to as AIPS
cells) with the features of replicatively senescent cells (hereafter
referred to as RS cells), the characteristics of AIPS and RS cells
were compared. We determined the contents and function of the
lysosomes and mitochondria, ROS generation, and proteasomal
activity and carried out flow cytometry to quantitate the
autofluorescence of the cells. Even at early passages, the stable
cell lines with autophagy impairment mediated by RNAi against
ATG7, ATG12, or Lamp2 showed increased autofluorescence,
mitochondria and lysosome content, and ROS generation, but
had decreased mitochondrial membrane potentials, compared to
cells expressing control shRNA (Fig. S1). Autofluorescence was
increased over 20-fold in both AIPS cells and RS cells (Fig. 3A). A
previous report indicated that autophagy impairment would
induce mitochondrial dysfunction and ROS generation [26].
Senescent cells exhibit an increase in organellar contents,
including lysosomes and mitochondria [27]. AIPS cells showed
a high lysosomal and mitochondrial mass similar to RS cells
(Fig. 3B and 3D). Senescent cells are known to exhibit a
depolarization of the mitochondrial membrane potential [28] and
decreased cellular ATP content [29]. AIPS cells showed a
decreased mitochondrial membrane potential compared to
control cells (Fig. 3E). Moreover, these cells had approximately
50% of the total cellular ATP content compared to the control
cells, which was similar to that seen in RS cells (Fig. 3G).
Similarly, the glycolytic portion of ATP generation, which was
calculated as the oligomycin-insensitive portion of ATP content
divided by the total ATP content in each sample, increased from
25% to 50% in both AIPS cells and RS cells compared to the
controls.
Senescent cells increase levels of lipofuscin, and the loading of
artificial lipofuscin-like molecules on cells hampers lysosomal
vacuolar ATPases, which consequently increases the lysosomal pH
[30–31]. In this regard, we compared the lysosomal pH of AIPS
cells and RS cells with control cells. As expected, the lysosomal pH
in AIPS cells as well as RS cells was higher than in the control cells
(Fig. 3C). In both cases, senescence increased the lysosomal pH by
approximately 1 pH unit in the cells.
Senescent cells increase ROS generation. As expected, both
AIPS and RS cells had ROS levels approximately 9-fold and 12-
fold higher than control cells, respectively, based on DHR123 for
hydroxyl radicals and hydrogen peroxides, and MitoSOX for
superoxide anions, respectively (Fig. 3F).
Activities of cathepsins, which are major proteolytic enzymes in
lysosomes, and proteasomes, are known to be decreased in
senescent cells [32–33]. The proteasome activities decreased by
approximately 50% in both AIPS and RS cells compared to young
cells after normalizing the protein contents of the samples (Fig. 3I).
In agreement with these results, western blot of the samples using
an anti-ubiquitin antibody showed an increase in poly-ubiquiti-
nated proteins in both types of senescent cells. Furthermore, the
amounts of poly-ubiquitinated proteins were much higher in AIPS
Figure 2. Autophagy impairment-induced prematurely senescent cells show similar morphology as shown in replicatively
senescent cells. Electron micrograph of stable cell lines at early passage (A–D) and in a senescent state (E–H). (A and E) control cell line (shNeg); (B
and F) ATG7-knockdown cell line (shATG7); (C and G) ATG12-knockdown cell line (shATG12); (D and H) Lamp2-knockdown cell line (shLamp2). Black
arrows indicate autophagosome filled with undigested materials (AVi) and white arrows indicate autolysosome filled with partially degraded
materials or multi-vesicular/lamellated structures (AVd).
doi:10.1371/journal.pone.0023367.g002
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observed increases in poly-ubiquitinated proteins in vitro and in vivo
during inhibition of autophagy [34–36]. In addition, the cathepsin
activity decreased by approximately 50% in both types of
senescent cells compared to young cells after normalization of
the lysosomal mass (Fig. 3H). Although the overall lysosomal mass
increased in senescent cells, the data indicated that at least half of
the lysosomes were dysfunctional due to the decreased enzyme
activity as a result of the altered pH (Fig. 3B–C, H). In addition,
similar results were obtained in AIPS cells when transfected with
ATG7 or Lamp2 siRNA, including increases of autofluorescence,
organellar contents, and ROS as well as organellar dysfunctions,
such as an increase in lysosomal pH and decrease of mitochondrial
membrane potential (Fig. S2).
Down-regulation of mTOR and autophagy pathways in
prematurely senescent cells
When components related to the mTOR pathway in both types
of senescent cells were monitored, the levels of mTOR or
phosphorylated mTOR (p-mTOR) were not markedly changed.
However, the levels of S6K1 and phosphorylated S6K1 (p-S6K1),
a downstream target of mTOR complex 1 (mTORC1), decreased
in both types of senescent cells as well as the level of
phosphorylated ribosomal S6 protein (p-S6), which is a down-
stream target of S6K1 (Fig. 4A). Unexpectedly, 4E-BP1, a
repressor of translation initiation factor eIF4E and also a
downstream target of mTORC1, was barely expressed in cells
undergoing both types of senescence (Fig. 4A). These results
suggest that the activity of mTORC1 might decrease in senescent
cells, even though the levels of mTOR and p-mTOR were not
changed. In addition, protein synthesis, which is one of the cellular
functions regulated by mTORC1, decreased by approximately
40% in RS and AIPS cells compared to young cells (data not
shown). This observation may have been partially due to the
decrease of S6K1.
Furthermore, the changes in the expression of components
related to the autophagy pathway in these cells were monitored.
Beclin-1 is a component of the class III PI3 kinase complex and is
required for autophagy initiation by various stimuli, such as
nutrient starvation, hypoxia, growth factor withdrawal, and
rapamycin treatment [24]. The formation of the autophagosome
after the initiation of autophagy requires the ubiquitin-like (Ubl)
protein system, including LC3 and ATG12, as well as the Ubl-
conjugating system, including ATG3 and ATG7. The C-terminal
glycine of LC3 is attached to phosphatidylethanolamine (PE), and
the C-terminal glycine of ATG12 is attached to ATG5 [37]. The
Figure 3. Cells in autophagy impairment-induced premature senescence show the same senescent features as cells in replicative
senescence. All experiments were performed on stable cell lines at passage 8. Flow cytometric analysis of autofluorescence (A), lysosomal contents
using LytoTracker Red (B), lysosomal pH using FITC-dextran (C), mitochondrial contents using MitoTracker Green FM (D), mitochondrial membrane
potential using JC-1 (E), mitochondrial ROS levels using DHR123 and MitoSOX (F), and cathepsin activity using Z-FR-4MbNA as a substrate (H).
Luminometric analysis of cellular ATP contents (G) and cell-based proteasome activities (I).
doi:10.1371/journal.pone.0023367.g003
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both types of senescence. Moreover, the level of beclin-1 gradually
decreased in siRNA-transfected cells, which lead to autophagy
impairment (Fig. 4B). RNAi-mediated knockdown of ATG7
efficiently decreased ATG12-ATG5 conjugates as well as the
expression of ATG7 in cells. In addition, the level of ATG7 was
significantly decreased in cells undergoing replicative senescence
or premature senescence induced by RNAi-mediated knockdown
of Lamp2 (Fig. 4B). ATG12-ATG5 conjugates were also modestly
reduced in both types of senescent cells (Fig. 4B), suggesting that
the reduction in the levels of ATG7 and ATG12-ATG5 conjugates
might be a common phenomenon during cellular senescence.
Moreover, the decrease in beclin-1 and ATG7 levels during
senescence may be responsible for the reduction of ATG12-ATG5
conjugates. Since SQSTM1/p62 (hereafter referred to as p62) has
a ubiquitin-associated domain that is capable of interacting with
ubiquitinated proteins, and an LC3-interacting region (LIR)/LC3
recognition sequence (LRS) capable of interacting with LC3, p62
can transport ubiquitinated protein targets to autophagosomes
that are destined for degradation [38]. Recently, it was shown that
p62 forms SDS-resistant high molecular weight polymers, and
therefore p62 monomer is decreased in senescent cells. These
polymers are thought to represent inclusion bodies of ubiquiti-
nated protein aggregates [39]. As previously reported, the level of
the p62 monomer was markedly decreased in cells undergoing
both types of senescence (Fig. 4B). In addition, LC3B, an isoform
of LC3, was markedly increased in cells undergoing both types of
senescence. The increase of the PE-conjugated form (type II) of
LC3B was more noticeable than the increase in the type I of LC3B
in AIPS cells (Fig. 4B). This increase of LC3B type II was
maximized at day 12 and mildly attenuated at day 32. In addition,
the increase of LC3B type II in senescent cells would not be due to
the increased autophagic flux, but rather due to the attenuated
autophagic flux, since the levels of LC3B type II/type I ratio were
more prominently increased in early-passaged cell lines upon
inhibition of autophagic flux by the lysosomal inhibitor monensin
(Fig. 5). In agreement with the increase in lysosomal mass of cells
undergoing both types of senescence (Fig. 3B), the level of
Figure 4. Several factors involved in the mTOR and autophagy pathways are commonly reduced in replicative senescence and
premature senescence induced by autophagy impairment. Cells were transfected with siRNA against ATG7 and Lamp2 every 3 d for the
indicated times. When the cells were confluent they were passaged. (2) denotes cells transfected with negative siRNA every 3 d for 32 d. At day 24
after transfection with siRNA against ATG7 and Lamp2, the cells showed high SA b-gal activity, as shown in Fig. S1B. (A) Decreased expression of p-
S6K1, S6K1, p-S6, and 4E-BP1 in the mTOR pathway. (B) Decreased expression of beclin-1, ATG7, p62/SQSTM1, and ATG12-ATG5 conjugates as well as
increased expression of LC3B and Lamp2a in the autophagy pathway. (C) Increased expression of p53, p21waf1, and p16ink4a as well as components
of the electron transport chain, Sdhb and COX2. (D) A comparison of the accumulation of poly-ubiquitinated proteins in prematurely senescent cells
induced by autophagy impairment and replicative senescent cells. Note that the poly-ubiquitinated proteins with a very high molecular weight (MW)
over 250 kD were highly accumulated in prematurely senescent cells induced by autophagy impairment compared to the replicative senescent cells.
doi:10.1371/journal.pone.0023367.g004
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macroautophagy [40] and chaperone-mediated autophagy (CMA)
[41], was also markedly increased in these cells (Fig. 4B), and
RNAi-mediated knockdown of Lamp2 efficiently decreased the
expression of Lamp2a in these cells.
These results suggest that the lowered levels of beclin-1, ATG7,
ATG12-ATG5 conjugate, and p62 monomer may be responsible
for the reduced autophagy activity observed in senescent cells. In
agreement with the observed increase in mitochondrial mass in
cells undergoing both types of senescence (Fig. 3D), the levels of
succinate dehydrogenase complex subunit B (Sdhb; complex II)
and cytochrome c oxidase subunit II (COX2; complex IV)
increased markedly in cells undergoing both types of senescence
(Fig. 4C). The fluorescent dye staining of lysosomes and
mitochondria (Fig. 3B and 3D), and the immunoblot of Lamp2a
in the lysosome and Sdhb and COX2 in the mitochondria
(Fig. 4B–C), all showed that the organellar contents in senescent
cells were indeed increased compared to control. However, these
organelles had clear functional defects, as shown by activity
analyses of the lysosomes (Fig. 3C and 3H) and mitochondria
(Fig. 3E and 3G).
Autophagy impairment-induced premature senescence
is ROS-dependent and p53-dependent
The increased ROS generation, which mainly originates from
mitochondrial dysfunction, can activate the p53 tumor suppressor
pathway and result in premature senescence [42]. In our study, the
stable cell lines with autophagy impairment showed mitochondrial
dysfunction (decreased mitochondrial membrane potential) with
the increased mitochondrial ROS generation at the early passage
compared to control cells (Fig. S1C-D). Accordingly, we
performed experiments to determine the localization of p53
protein. At early passage, the immunofluorescence of p53 in
autophagy-impaired cell lines showed a moderate signal of p53,
which was mainly localized in nuclei, while the control cell line
showed a very faint p53 signal in the nuclei. As expected, however,
during senescence, all cell lines including the AIPS and RS cells
showed a strong p53 signal in nuclei (data not shown). In addition,
the levels of p53, its downstream target p21waf1, and the CDK
inhibitor p16ink4a were all increased in AIPS cells as well as in RS
cells (Fig. 4C). The levels of p53, p21waf1, and p16ink4a reached a
maximum level at day 12 and remained at that level in the AIPS
cells. Stress-induced p53 activation might induce apoptosis or
autophagy through the transcriptional induction of DRAM,
PUMA, or NOXA [43]. However, p53 induced by autophagy
impairment did not activate the expression of DRAM, PUMA, or
NOXA (data not shown). Therefore, although p53 is activated
through autophagy impairment, we excluded the possibility that
apoptosis or autophagy regulated by p53 induction affects
premature senescence through autophagy impairment. Given that
autophagy-impaired cell lines produced more ROS compared to
the control cell line, it is anticipated that autophagy impairment
would stress the cells by the increased ROS generation, and that
oxidative stress-mediated p53 activation would force the cells into
premature senescence. Therefore, we examined whether the
inhibition of p53 or scavenging of ROS would be effective in
delaying premature senescence induced by autophagy impair-
ment. Pifithrin-a (PFT), a chemical inhibitor of p53 [44], and N-
acetyl cysteine (NAC), an antioxidant, were administered every 3 d
to the control cell lines and stable cell lines of autophagy
Figure 5. Autophagic flux decreases in HDFs during senescence. At early passage and at senescence, stable cell lines were incubated with or
without 40 mM monensin for 2 h. Cells were then collected and used for western blot analysis. (A and B) Representative western blot; (C) Bars
represent the level of LC3B type II/type I ratio calculated by normalizing the LC3B type II/type I ratio from monensin-treated samples with LC3B type
II/type I ratio from monensin-untreated samples.
doi:10.1371/journal.pone.0023367.g005
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inhibit p53 and ROS scavenging, respectively. When NAC or PFT
were administered to the cells, the replicative lifespan increased by
approximately 4–5 population doublings (Fig. 6). In addition,
knockdown of p53 using siRNA increased the cellular lifespan of
the cell lines by approximately 2–4 population doublings for 30 d
(data not shown). Two months after the drug treatment, the cells
were assayed for SA-b-gal activity. As expected, almost all of the
cells in the untreated group, which had a population doubling time
over 18 d, stained positive for SA-b-gal activity. However,
approximately half of the cells in the PFT- or NAC-treated
groups, which had a population doubling time below 9 d, stained
positive for SA-b-gal activity (Fig. 7A).
The senescent phenotypes were compared between the control
and PFT- or NAC-treated cell lines. The increase in autofluores-
cence and organellar contents (lysosome and mitochondria) was
markedly reduced in PFT- or NAC-treated cell lines compared to
control cell lines (Fig. 7B-D). In addition, the increase in
mitochondrial ROS was markedly decreased in drug-treated cell
lines compared to control cell lines (Fig. 7F–G). Furthermore,
depolarization of the mitochondrial membrane potential was
markedly attenuated in PFT- or NAC-treated cell lines compared
to the control (Fig. 7E). These data implicate that premature
senescence induced by autophagy impairment can be delayed
morphologically and functionally by inhibiting p53 activation or
ROS scavenging (Fig. 6 and Fig. 7).
We next examined the changes in expression of components
related to mTOR pathway, autophagy, and p53 pathways in PFT-
and NAC-treated cell lines as well as p53-knockdown cell lines
compared to the control. The levels of mTOR or p-mTOR were
not significantly altered in PFT- or NAC-treated cell lines, or p53-
knockdown cell lines compared to the control (Fig. 8A and 8D).
However, the levels of S6K1, p-S6K1, p-S6, beclin-1, ATG7, and
p62 monomer were restored in PFT- and NAC-treated cell lines as
well as p53-knockdown cell lines compared to the control cell lines
(Fig. 8A, B, D, E). However, 4E-BP1 was restored in the NAC-
treated cell lines and p53-knockdown cell lines, but not in the PFT-
treated cell lines (Fig. 5A). In contrast, the level of ATG12-ATG5
Figure 6. NAC and pifithrin-a (PFT) delay the premature senescence induced by autophagy impairment. 5 mM NAC or 5 mM PFT was
administered every 3 d to stable cell lines from a population doubling time of 6 d. Upon confluency, cells were passaged and counted for 2 months.
doi:10.1371/journal.pone.0023367.g006
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whereas ATG12-ATG5 conjugates were restored in p53-
knockdown cell lines (Fig. 8B and 8E). Moreover, the factors
that were increased in cells undergoing both types of senescence,
including the type II form of LC3B, Lamp2a, COX2, p53,
p21waf1, and p16ink4a, were markedly reduced in PFT- and
NAC-treated cell lines as well as p53-knockdown cell lines
compared to control cells (Fig. 8B-C and 8E-F). The level of Sdhb
was markedly reduced in NAC-treated but not PFT-treated cell
lines compared to control cells (Fig. 8C). In addition, the level of
the well-known DNA damage marker, c-H2AX, was reduced in
PFT- or NAC-treated cell lines compared to controls
(Fig. 8C).Taken together, the expression levels of components
related to mTOR pathway, autophagy pathway, and p53 and
p21waf1 were all similarly restored in NAC- or pifithrin-a-treated
cells as well as in p53 knockdown experiments.
Overall, ROS scavenging by NAC was slightly more effective
than PFT-mediated p53 inhibition in the restoration of protein
expression in AIPS cells (Fig. 8A–C). Moreover, the stable cell
lines of autophagy impairment had already exhibited mitochon-
drial dysfunction and increased mitochondrial ROS generation at
early passages compared to control cells (Fig. S1). Therefore, these
data suggest that the activation of p53, which presumably
occurred as a result of the increased ROS generation originating
from dysfunctional mitochondria, might have an important role in
the premature senescence induced by autophagy impairment.
Discussion
In this study, we have demonstrated that autophagy impairment
induces premature senescence in human primary fibroblasts. In
addition, we showed that several important components that have
been implicated in the mTOR pathway (S6K1, p-S6, and 4E-BP1)
or autophagy pathway (Beclin-1, ATG7, p62 monomer, and
ATG12-ATG5 conjugates) are down-regulated in both RS cells
and AIPS cells. Furthermore, we have shown that p53 inhibition
or ROS scavenging can adjust premature senescence, induced by
autophagy impairment, and can also reverse the changes seen in
the mTOR and autophagy pathways. Therefore, our findings
suggest that autophagy impairment can induce premature
senescence in human primary fibroblasts through activation of
the p53 tumor suppressor pathway due to increased ROS
generation from an accumulation of dysfunctional mitochondria,
which are usually eliminated by autophagic degradation.
Figure 7. NAC and pifithrin-a (PFT) delay the expression of senescence phenotypes in prematurely senescent cells induced by
autophagy impairment. Stable cell lines were cultured as shown in Fig. 6. Two months after drug treatment, the cells were assayed for the
expression of SA-b-gal activity. Cell lines cultured without drugs showed high SA-b-gal activity. These cells were assayed for determination of
expression levels of senescence phenotypes. (A) Left panel: Representative micrograph of SA-b-gal staining in stable cell lines cultured with or
without NAC and PFT; Right panel: Bars represent the percentage of SA-b-gal positive cells. Flow cytometric analysis of autofluorescence (B),
lysosomal content using LytoTracker Red (C), mitochondrial content using MitoTracker Green FM (D), mitochondrial membrane potential using JC-1
(E), and mitochondrial ROS levels using DHR123 (F) and MitoSOX (G) in stable cell lines cultured with or without NAC and PFT.
doi:10.1371/journal.pone.0023367.g007
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are reduced during premature senescence. (A–C) Stable cell lines were cultured as shown in Fig. 5. (D–F) Stable cell lines were transfected with
negative siRNA and siRNA to p53 every 3 d for 5 weeks. P and N denote PFT and NAC, respectively, and (2) and p53 denote negative siRNA and siRNA
to p53, respectively. (A and D) Restoration of expression levels of p-S6K1, S6K, p-S6P, and 4E-BP1 in the mTOR pathway by PFT and NAC treatment,
and by knockdown of p53. (B and E) Restoration of expression levels of beclin-1, ATG7, and p62/SQSTM1 as well as decreased expression levels of
LC3B and Lamp2a in the autophagy pathway by PFT and NAC treatment as well as knockdown of p53. (C and F) Decreased expression levels of p53,
p21waf1, p16ink4a, and c-H2AX as well as components of the electron transport chains, Sdhb and COX2, by PFT and NAC treatment, and decreased
expression levels of p53 and p21waf1 by knockdown of p53.
doi:10.1371/journal.pone.0023367.g008
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PLoS ONE | www.plosone.org 9 August 2011 | Volume 6 | Issue 8 | e23367Autophagy is a catabolic process by which cytoplasmic
components, including macromolecules and organelles, are
degraded. Autophagy plays a role in the physiology of several
cellular processes, pathogenesis of several disease processes, and
health [1]. Many studies have shown that autophagy activation
can prolong the lifespan of organisms from yeast to flies [2–6] and
that autophagy activation is important for lifespan extension [5,9–
11]. Moreover, a conditional knockout of ATG7 in mice, which is
an essential gene for autophagy, caused pathological defects in the
liver [34], neuro-degeneration, and early death [35]. These studies
suggest that autophagy-activating interventions might be useful
tools for promoting longevity. On the other hand, it has been
reported that overexpression of ULK3, an isoform of ULK1,
induces autophagy activation and reduces replicative lifespan of
human fibroblasts by approximately 20% [23]. Therefore, a bell-
shaped relationship between autophagy activity and cell survival
has been proposed. The maintenance of physiological levels of
autophagy would be essential for normal cellular homeostasis,
while a deficiency or excessive autophagy might be unfavorable
[45]. Interestingly, ULK3, but not ULK1, has been reported to be
involved in the sonic hedgehog signaling pathway [46], suggesting
that the excessive autophagy by either the overexpression of
ULK3 or an as yet unidentified function might affect replicative
lifespan. Therefore, it remains to be determined whether excessive
autophagy induced by the overexpression of genes other than
ULK3 can still reduce replicative lifespan. In this aspect, we have
shown in this study that autophagy impairment induces premature
senescence in a p53-dependent and ROS-dependent manner.
To our knowledge, this is the first report demonstrating that the
protein levels of S6K1 and 4E-BP1 (mTOR pathway) as well as
Beclin-1 and ATG7 (autophagy pathway) are decreased in
senescent cells. Phosphorylations of S6K1 at Thr421/Ser424
and at Thr389 were diminished in replicatively senescent
fibroblasts, and phosphorylation of ribosomal S6 protein was
severely reduced in these cells [47]. Thus, the decrease of protein
synthesis might be related to the diminished levels of the proteins
and phosphorylation status of S6K1 and S6 protein, even though
the levels of mTOR and p-mTOR were unchanged. Although the
mechanism by which the different forms of autophagy decrease
with aging is as yet unclear, it is well accepted that the functional
decline of autophagy is involved in the aging process, and the
prevention of this decline should have a beneficial effect on
lifespan [48–49]. Recently, chaperone-mediated autophagy
(CMA) has been reported to decrease with aging due to a
reduction of the lysosomal receptor for CMA. In addition, the
restoration of CMA function with a knock-in of the lysosomal
receptor for CMA in the liver results in an improvement of hepatic
function in aging animals [50]. In contrast to CMA, the
mechanism by which macroautophagy, another form of autoph-
agy, decreases with aging is not yet known. In this study, we
demonstrated that Beclin-1 and ATG7 levels are decreased in
senescent cells, suggesting that the initiation step of autophagy as
well as the elongation step of the autophagosome might be
damaged in senescent cells as previously reported [51]. In
addition, the decline of the p62 monomer, which is required for
the transport of poly-ubiquitinated proteins into the autophago-
some, may induce defective clearance and accumulation of poly-
ubiquitinated proteins in cells as previously reported [39].
Therefore, our study has shown that autophagy in senescent cells
is damaged, at least in part, at multiple steps of the pathway,
including autophagic initiation, autophagosome formation, and
the degradation of poly-ubiquitinated proteins.
In conclusion, our findings indicate that autophagy impairment
can induce premature senescence in human fibroblasts through
the activation of p53 by increased ROS generation originating
from dysfunctional mitochondria. Moreover, our study has shown
that during senescence, the protein levels of S6K1, 4E-BP1, beclin-
1, and ATG7 are decreased. Further studies are needed to test
whether restoration of the factors of the autophagy pathway can
improve the autophagic function of senescent cells, which would
result in a delay of the cellular aging process and final extension of
cellular lifespan.
Materials and Methods
Cell cultures
Normal human diploid fibroblasts (HDFs) were obtained from
the foreskin of an 11 year-old donor (M11 strain) and 6 year-old
donor (M6 strain) as described previously [52]. HDFs were
cultured in Dulbecco’s modified Eagle’s medium (DMEM)
containing 25 mM glucose supplemented with 10% fetal bovine
serum (FBS), 100 units/ml penicillin, and 100 ug/ml streptomy-
cin. When confluent, the cells were split 1:4 during early passages
and 1:2 during late passages. The culture medium was changed
every 4 d. The number of population doublings (PDs) (n) was
calculated using the equation: n=log2 F/I, where F and I are the
numbers of cells at the end and those seeded at the beginning of
one passage, respectively. When the population doubling time of
the cells was over 21 d, the cells were considered to be senescent.
Cellular senescence was confirmed by the expression of SA-ß-gal
activity. For transfection of siRNA, the cells were seeded at a 1/4
dilution in the culture dish 3-4 d before the transfection. After
culturing the cells overnight (O/N), the siRNAs were transfected
with Lipofectamine RNAiMAX (Invitrogen) according to the
manufacturer’s protocol. When the cells were confluent, they were
counted, passaged, and transfected with siRNA every 3 d for 24 d.
All siRNAs were purchased from Bioneer. The siRNA sequences
were as follows: ATG7, sense strand, CAG CUA UUG GAA
CAC UGU A, LAMP2, sense strand, GAA AAU GCC ACU
UGC CUU U, p53, sense strand, CAC UAC AAC UAC AUG
UGU A and the negative control, sense strand, CCU ACG CCA
CCA AUU UCG U. To establish stable cell lines, the cells (M11
strain) were infected with Lentiviruses expressing shRNA to
ATG7, ATG12, or LAMP2 (Santa Cruz) at an early passage and
were selected with 2 mg/ml puromycin (Sigma) for 7 d. When
confluent, the cells were trypsinized and split by 1:4. This time
point was designated as PD 0. Pooled clones were passaged until
they reached senescence. To determine autophagic flux, early-
passaged (at passage 3) cell lines and senescent (population
doubling time over 15 d) cell lines were incubated with or without
40 mM monensin (Sigma) for 2 h.
SA-b-Gal staining
SA-b-Gal staining was carried out as previously described by
Dimri et al. (1995). The cells were stained after fixation in 3%
formaldehyde for 5 min with freshly prepared SA-b-Gal staining
solution overnight at 37uC. The number of SA-b-Gal-positive cells
in randomly-selected fields was expressed as a percentage of all
cells counted.
Western blot analysis
The cells were lysed with RIPA buffer (50 mM Tris-Cl, pH 7.5,
150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate,
and 0.1% SDS) supplemented with a protease inhibitor mixture
(Sigma), sodium fluoride, and sodium orthovanadate (Sigma).
After 20 min incubation on ice, the cell lysates were collected after
centrifugation. The protein concentration in the lysates was
determined using the BCA protein assay reagent (Bio-Rad).
Autophagy Impairment-Induced Premature Senescence
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and transferred to a nitrocellulose membrane (Millipore). The
blots were then incubated with antibodies against p-mTOR
(S2448), mTOR, p-S6K (T389), S6K, p-S6 protein, 4E-BP1,
Beclin-1, ATG7, ATG12, LC3B (Cell Signaling), p62/SQSTM1,
p53, p21waf1, Lamp2a, ubiquitin (Santa Cruz), c-H2AX,
p16ink4a (Pharmingen), Sdhb, COX2 (MitoScience), and b-actin
(Sigma). The protein bands were visualized by using horseradish
peroxidase-conjugated secondary antibodies and SuperSignal
West Pico or Femto substrate (Thermo Scientific).
Measurement of autofluorescence, ROS, organellar
contents, and mitochondrial membrane potential
For quantitation of autofluorescence, the cells were washed with
PBS, trypsinized, collected in PBS, and analyzed on a FACSCa-
liber (Beckton Dickson). For quantitation of mitochondrial ROS,
the cells were incubated with 5 mM DHR123 (Anaspec) and
0.2 mM MitoSOX (Invitrogen) for 30 min at 37uC, washed with
PBS, trypsinized, collected in PBS, and analyzed on a FACSCa-
liber (Beckton Dickson). For quantitation of organellar contents,
the cells were incubated with 60 nM MitoTracker Green FM and
50 nM LysoTracker Red (Invitrogen) for 30 min at 37uC, washed
with PBS, trypsinized, collected in PBS, and analyzed on a
FACSCaliber (Beckton Dickson). For measurement of the
mitochondrial membrane potential, the cells were incubated with
0.3 mg/ml JC-1 (Invitrogen) for 30 min at 37uC and prepared for
FACS analysis as previously described [53]. The results were
analyzed by using Cell Quest 3.2 software (Beckton Dickson) for
analysis.
Measurement of lysosomal pH
The lysosomal pH was measured by flow cytometry as
previously described [54–55]. The cells were incubated in normal
medium containing 3 mg/ml FITC-dextran (150 kD; Poly-
sciences) for 3 d, washed with PBS, and subsequently incubated
in normal medium for 24 h. Cells were washed with PBS,
trypsinized, collected in PBS, and analyzed on a FACSCaliber
(Beckton Dickson). The excitation wavelength was 488 nm and
the emission fluorescence for FITC was monitored at 530 nm (FL-
1) and 610 nm (FL-2). The FL-1/FL-2 ratio of the samples was
converted to pH using a standard curve from cells loaded with
FITC-dextran. For construction of a standard curve, the cells that
were loaded with FITC-dextran were prepared for FACS analysis.
Prior to analysis, the cells were incubated in phosphate-citrate
buffers (pH 4.0–7.0) containing 50 mM NaN3, 50 mM 2-deox-
yglucose, and 10 mM Nigericin for 20 min. The background
autofluorescence from control cells that were incubated in normal
medium without FITC-dextran was subtracted from the fluores-
cence of cells that were incubated with FITC-dextran.
Measurement of cathepsin activity
The cathepsin activity was measured by flow cytometry as
previously described [56–57]. The cells were incubated with or
without leupeptin and 10 mM E-64d (Calbiochem) for 30 min and
were prepared for FACS analysis. Prior to analysis, the cells were
resuspended in serum-free and phenol red-free DMEM containing
50 mM 5-nitrosalicylaldehyde (5-NSA) with or without leupeptin
and 10 mM E-64d. The cells were then incubated for 2 h at 37uC
with 0.2 mM Z-Phe-Arg-4-methoxy-b-naphthylamine (Z-FR-
4MbNA). The cells were washed with PBS 3 times and the
fluorescence was monitored at excitation 488 nm/emission
530 nm. The background autofluorescence from cells incubated
with only 5-NSA was subtracted from the fluorescence of cells
incubated with Z-FR-4MbNA. The specific activity of cathepsin
was calculated by subtracting the fluorescence of cells with
inhibitors from the fluorescence of cells without inhibitors.
Measurement of cellular ATP levels
The cells were incubated with or without 8 mg/ml oligomycin
(Sigma) for 24 h, lysed with lysis buffer, and the ATP content was
measured using the ViaLight Plus Kit (Lonza) according to the
manufacturer’s instructions. For measurements of relative ATP
content, the luminescence of each sample was normalized with the
protein content in each sample.
Measurement of cell-based proteasome activity
The cells were incubated with or without proteasome inhibitors
(BioMol) for 24 h, lysed with lysis buffer, and the proteasome
activity was measured using the Proteasome-Glo cell-based assay
Kit (Promega) according to the manufacturer’s instructions. To
measure the relative proteasome activity, the luminescence of each
sample was normalized with the protein content in each sample.
Electron microscopy (EM)
Early passaged cell lines and senescent cell lines were
trypsinized, washed with PBS, and fixed in 2% glutaraldehyde
containing 2% paraformaldehyde in 30 mM phosphate buffer
(pH 7.4) for 2 h at RT. Cells were washed with 0.2 M HEPES
(pH 7.4) and 0.1 M phosphate buffer (pH 7.4), consecutively.
Cells were then post-fixed in 1% OsO4 for 2 h at RT. After
dehydration in graded series of ethanol, the cells were embedded
in Epon 812 (Fluka) and polymerized at 60uC for 2 d. Thin
sections were cut on a Leica EM UC6 and then counterstained
with uranyl acetate and lead citrate. EM images were acquired
from thin sections using a JEOL JEM-1400 transmission electron
microscope equipped with Orius SC1000 digital camera (Gatan,
Warrendale, U.S.A.).
Supporting Information
Figure S1 Stable cell lines with autophagy impairment
show increased ROS at early passages. At passage 2, stable
cell lines were used for flow cytometric analysis of autofluorescence
(A), lysosomal contents using LytoTracker Red and mitochondrial
contents using MitoTracker Green FM (B), mitochondrial
membrane potential using JC-1 (C), and mitochondrial ROS
levels using DHR123 and MitoSOX (D).
(TIFF)
Figure S2 Premature senescence induced by autophagy
impairment using siRNA show the same senescent
features as replicative senescence. Cells transfected with
siRNA every 3 d for 24 d were used for flow cytometric analysis of
autofluorescence (A), lysosomal contents using LytoTracker Red
(B), lysosomal pH using FITC-dextran (C), mitochondrial contents
using MitoTracker Green FM (D), mitochondrial membrane
potential using JC-1 (E), and mitochondrial ROS levels using
DHR123 and MitoSOX (F).
(TIFF)
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